Brave Bio, Inc. — Form D
Brave Bio, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-06. The offering totals $8.8M, of which $5.3M was reported sold. Industry: Other.
Offering
- Filed: 2021-10-06
- Form: D
- Accession: 0001886666-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $8.8M
- Amount sold: $5.3M
- Remaining: $3.5M
- Investors: 3
- Date of first sale: 2021-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-415847
Issuer
- Name: Brave Bio, Inc.
- CIK: 0001886666
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 420 BOYLSTON STREET #501, BOSTON, MA, 02116
- Phone: 7188568198
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Meredith Fisher | Director | Half Moon Bay, CA |
| Jacqueline Grant | Director | Durham, NC |
| Meredith Fisher | Executive Officer | Half Moon Bay, CA |
More